These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1350199)

  • 1. Inhibition of human, ovine, and baboon neutrophil elastase with Eglin c and secretory leukocyte proteinase inhibitor.
    Junger WG; Hallström S; Redl H; Schlag G
    Biol Chem Hoppe Seyler; 1992 Mar; 373(3):119-22. PubMed ID: 1350199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of the inhibition of human pancreatic elastase by recombinant eglin c. Influence of elastin.
    Faller B; Dirrig S; Rabaud M; Bieth JG
    Biochem J; 1990 Sep; 270(3):639-44. PubMed ID: 1700695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different susceptibility of elastase inhibitors to inactivation by proteinases from Staphylococcus aureus and Pseudomonas aeruginosa.
    Sponer M; Nick HP; Schnebli HP
    Biol Chem Hoppe Seyler; 1991 Nov; 372(11):963-70. PubMed ID: 1686554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic studies on the interaction of eglin c with human leukocyte elastase and cathepsin G.
    Braun NJ; Bodmer JL; Virca GD; Metz-Virca G; Maschler R; Bieth JG; Schnebli HP
    Biol Chem Hoppe Seyler; 1987 Apr; 368(4):299-308. PubMed ID: 3649242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors.
    Bergenfeldt M; Axelsson L; Ohlsson K
    Scand J Clin Lab Invest; 1992 Dec; 52(8):823-9. PubMed ID: 1362620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific cleavage of secretory leukoprotease inhibitor by neutrophil elastase and saliva.
    Masuda K; Suga T; Takeuchi A; Kanesaki M; Imaizumi A; Suzuki Y
    Biochem Pharmacol; 1994 Aug; 48(4):651-7. PubMed ID: 8080437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of the interaction of chymotrypsin with eglin c.
    Faller B; Bieth JG
    Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):27-32. PubMed ID: 1741752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the elastase inhibitor eglin C in porcine endotoxin shock.
    Siebeck M; Hoffmann H; Weipert J; Fritz H
    Circ Shock; 1992 Mar; 36(3):174-9. PubMed ID: 1351797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functions of the N-terminal domain of secretory leukoprotease inhibitor.
    Ying QL; Kemme M; Simon SR
    Biochemistry; 1994 May; 33(18):5445-50. PubMed ID: 7910033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of plasma proteinase inhibitors and the secretory leucocyte proteinase inhibitor on pancreatic elastase-induced degradation of some plasma proteins.
    Håkansson HO; Ohlsson K
    Gastroenterol Jpn; 1992 Oct; 27(5):652-6. PubMed ID: 1358738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid.
    Sathe S; Sakata M; Beaton AR; Sack RA
    Curr Eye Res; 1998 Apr; 17(4):348-62. PubMed ID: 9561826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
    Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
    Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation.
    Llewellyn-Jones CG; Lomas DA; Stockley RA
    Thorax; 1994 Jun; 49(6):567-72. PubMed ID: 7912452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a trihexacontapeptide corresponding to the sequence 8-70 of eglin c and studies on the relationship between the structure and the inhibitory activity against human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
    Okada Y; Tsuboi S; Tsuda Y; Nagamatsu Y; Yamamoto J
    FEBS Lett; 1990 Oct; 272(1-2):113-6. PubMed ID: 2226822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free radicals inactivate human neutrophil elastase and its inhibitors with comparable efficiency.
    Dean RT; Nick HP; Schnebli HP
    Biochem Biophys Res Commun; 1989 Mar; 159(2):821-7. PubMed ID: 2784675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the inhibition of human leukocyte elastase by elafin, a 6-kilodalton elastase-specific inhibitor from human skin.
    Ying QL; Simon SR
    Biochemistry; 1993 Feb; 32(7):1866-74. PubMed ID: 8439544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory leukocyte protease inhibitor in cystic fibrosis.
    Stromatt SC
    Agents Actions Suppl; 1993; 42():103-10. PubMed ID: 8102834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
    Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
    J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory leukocyte protease inhibitor in the cervical mucus and in the fetal membranes.
    Helmig R; Uldbjerg N; Ohlsson K
    Eur J Obstet Gynecol Reprod Biol; 1995 Mar; 59(1):95-101. PubMed ID: 7781866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA binds neutrophil elastase and mucus proteinase inhibitor and impairs their functional activity.
    Belorgey D; Bieth JG
    FEBS Lett; 1995 Mar; 361(2-3):265-8. PubMed ID: 7698335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.